JP2015533598A - 可撓性要素、特に天然または合成の靭帯または腱を骨に固定するための装置 - Google Patents
可撓性要素、特に天然または合成の靭帯または腱を骨に固定するための装置 Download PDFInfo
- Publication number
- JP2015533598A JP2015533598A JP2015541190A JP2015541190A JP2015533598A JP 2015533598 A JP2015533598 A JP 2015533598A JP 2015541190 A JP2015541190 A JP 2015541190A JP 2015541190 A JP2015541190 A JP 2015541190A JP 2015533598 A JP2015533598 A JP 2015533598A
- Authority
- JP
- Japan
- Prior art keywords
- anchor
- insert
- bone
- flexible element
- silk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 136
- 210000002435 tendon Anatomy 0.000 title claims abstract description 41
- 210000003041 ligament Anatomy 0.000 title claims abstract description 31
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 62
- 239000001506 calcium phosphate Substances 0.000 claims description 56
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 51
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 51
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 51
- 238000003780 insertion Methods 0.000 claims description 34
- 230000037431 insertion Effects 0.000 claims description 34
- 239000000835 fiber Substances 0.000 claims description 29
- 239000004696 Poly ether ether ketone Substances 0.000 claims description 25
- 229920002530 polyetherether ketone Polymers 0.000 claims description 25
- 239000000463 material Substances 0.000 claims description 16
- 108010022355 Fibroins Proteins 0.000 claims description 14
- 230000000278 osteoconductive effect Effects 0.000 claims description 8
- 230000002138 osteoinductive effect Effects 0.000 claims description 8
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 5
- 235000011010 calcium phosphates Nutrition 0.000 claims description 5
- 239000000956 alloy Substances 0.000 claims description 4
- 229910045601 alloy Inorganic materials 0.000 claims description 4
- 229920001610 polycaprolactone Polymers 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 2
- 229910052918 calcium silicate Inorganic materials 0.000 claims description 2
- 239000000378 calcium silicate Substances 0.000 claims description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 2
- 239000004626 polylactic acid Substances 0.000 claims description 2
- 239000010936 titanium Substances 0.000 claims description 2
- 229910052719 titanium Inorganic materials 0.000 claims description 2
- CGMRCMMOCQYHAD-UHFFFAOYSA-J dicalcium hydroxide phosphate Chemical compound [OH-].[Ca++].[Ca++].[O-]P([O-])([O-])=O CGMRCMMOCQYHAD-UHFFFAOYSA-J 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 abstract 1
- 210000001264 anterior cruciate ligament Anatomy 0.000 description 113
- 210000002414 leg Anatomy 0.000 description 43
- 210000001519 tissue Anatomy 0.000 description 37
- 238000000034 method Methods 0.000 description 32
- 238000012360 testing method Methods 0.000 description 25
- 241001465754 Metazoa Species 0.000 description 21
- 108010013296 Sericins Proteins 0.000 description 19
- 238000012545 processing Methods 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 17
- 230000000694 effects Effects 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 15
- 238000000605 extraction Methods 0.000 description 14
- 238000001356 surgical procedure Methods 0.000 description 14
- 210000000689 upper leg Anatomy 0.000 description 14
- 238000010186 staining Methods 0.000 description 13
- 238000002513 implantation Methods 0.000 description 12
- 210000000629 knee joint Anatomy 0.000 description 12
- 238000011068 loading method Methods 0.000 description 12
- 238000005553 drilling Methods 0.000 description 11
- 210000000968 fibrocartilage Anatomy 0.000 description 11
- 241000282472 Canis lupus familiaris Species 0.000 description 10
- 238000013459 approach Methods 0.000 description 10
- 210000003127 knee Anatomy 0.000 description 10
- 241000282887 Suidae Species 0.000 description 9
- 230000035876 healing Effects 0.000 description 9
- 210000004417 patella Anatomy 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 7
- 230000007704 transition Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 210000002303 tibia Anatomy 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 238000004873 anchoring Methods 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 238000006073 displacement reaction Methods 0.000 description 5
- 230000011164 ossification Effects 0.000 description 5
- 230000008929 regeneration Effects 0.000 description 5
- 238000011069 regeneration method Methods 0.000 description 5
- 231100000241 scar Toxicity 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 206010015548 Euthanasia Diseases 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 210000001699 lower leg Anatomy 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 210000000963 osteoblast Anatomy 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 3
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 210000001188 articular cartilage Anatomy 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 210000002449 bone cell Anatomy 0.000 description 3
- 239000002639 bone cement Substances 0.000 description 3
- 229940112869 bone morphogenetic protein Drugs 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 238000011960 computer-aided design Methods 0.000 description 3
- UMGXUWVIJIQANV-UHFFFAOYSA-M didecyl(dimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC UMGXUWVIJIQANV-UHFFFAOYSA-M 0.000 description 3
- 239000003822 epoxy resin Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000002073 fluorescence micrograph Methods 0.000 description 3
- 210000003194 forelimb Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000002355 open surgical procedure Methods 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 229920000647 polyepoxide Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000255789 Bombyx mori Species 0.000 description 2
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 2
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000004439 collateral ligament Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000011833 dog model Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000000281 joint capsule Anatomy 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 238000010603 microCT Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 210000000426 patellar ligament Anatomy 0.000 description 2
- 229960000482 pethidine Drugs 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000007634 remodeling Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000009026 tissue transition Effects 0.000 description 2
- 238000007514 turning Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 208000025674 Anterior Cruciate Ligament injury Diseases 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 1
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023204 Joint dislocation Diseases 0.000 description 1
- 206010061223 Ligament injury Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- LYZGJWXNOGIVQA-UHFFFAOYSA-M Thiamylal sodium Chemical compound [Na+].CCCC(C)C1(CC=C)C(=O)NC([S-])=NC1=O LYZGJWXNOGIVQA-UHFFFAOYSA-M 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000003462 bioceramic Substances 0.000 description 1
- 239000005312 bioglass Substances 0.000 description 1
- 230000007227 biological adhesion Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000019347 bone phosphate Nutrition 0.000 description 1
- DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical class O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 description 1
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000006258 conductive agent Substances 0.000 description 1
- 230000002089 crippling effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000007783 downstream signaling Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001523 electrospinning Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000000445 field-emission scanning electron microscopy Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005541 medical transmission Effects 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 238000002663 nebulization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 238000013310 pig model Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000012414 sterilization procedure Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000004154 testing of material Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 229960001525 thiamylal sodium Drugs 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
- A61F2/0811—Fixation devices for tendons or ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
- A61F2/0805—Implements for inserting tendons or ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00933—Material properties bone or bone-like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0403—Dowels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0445—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors cannulated, e.g. with a longitudinal through-hole for passage of an instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0446—Means for attaching and blocking the suture in the suture anchor
- A61B2017/0448—Additional elements on or within the anchor
- A61B2017/045—Additional elements on or within the anchor snug fit within the anchor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0446—Means for attaching and blocking the suture in the suture anchor
- A61B2017/0456—Surface features on the anchor, e.g. ribs increasing friction between the suture and the anchor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
- A61F2/0811—Fixation devices for tendons or ligaments
- A61F2002/0817—Structure of the anchor
- A61F2002/0823—Modular anchors comprising a plurality of separate parts
- A61F2002/0835—Modular anchors comprising a plurality of separate parts with deformation of anchor parts, e.g. expansion of dowel by set screw
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
- A61F2/0811—Fixation devices for tendons or ligaments
- A61F2002/0847—Mode of fixation of anchor to tendon or ligament
- A61F2002/0852—Fixation of a loop or U-turn, e.g. eyelets, anchor having multiple holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
- A61F2/0811—Fixation devices for tendons or ligaments
- A61F2002/0847—Mode of fixation of anchor to tendon or ligament
- A61F2002/087—Anchor integrated into tendons, e.g. bone blocks, integrated rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
- A61F2/0811—Fixation devices for tendons or ligaments
- A61F2002/0876—Position of anchor in respect to the bone
- A61F2002/0888—Anchor in or on a blind hole or on the bone surface without formation of a tunnel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
- A61F2240/008—Means for testing implantable prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Rehabilitation Therapy (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
Abstract
Description
1. Parkkari, J., et al., The risk for a cruciate ligament injury of the knee in adolescents and young adults: a population-based cohort study of 46,500 people with a 9 year follow-up. British Journal of Sports Medicine, 2008. 42(6): p. 422-426.
2. Freeman, J.W.K., A.L, Recent Advancements in Ligament Tissue Engineering: The Usw of Various Techniques and Materials for ACL Repair. Recent Pat. Biomed. Eng, 2008. 1: p. 6.
3. Majewski, M., H. Susanne, and S. Klaus, Epidemiology of athletic knee injuries: A 10-year study. Knee, 2006. 13(3): p. 184-188.
4. Cooper, J.A., et al., Fiber-based tissue-engineered scaffold for ligament replacement: design considerations and in vitro evaluation. Biomaterials, 2005. 26(13): p. 1523-1532.
5. Vunjak-Novakovic, G., et al., Tissue engineering of ligaments. Annual Review of Biomedical Engineering, 2004. 6: p. 131-156.
6. Bach, B.R., et al., Arthroscopically assisted anterior cruciate ligament reconstruction using patellar tendon autograft - Five- to nine-year follow-up evaluation. American Journal of Sports Medicine, 1998. 26(1): p. 20-29.
7. Bach, B.R., et al., Single-incision endoscopic anterior cruciate ligament reconstruction using patellar tendon autograft - Minimum two-year follow-up evaluation. American Journal of Sports Medicine, 1998. 26(1): p. 30-40.
8. Strickland, S.M., J.D. MacGillivray, and R.F. Warren, Anterior cruciate ligament reconstruction with allograft tendons. Orthopedic Clinics of North America, 2003. 34(1): p. 41-+.
9. Badylak, S.F., et al., The Use of Xenogeneic Small-Intestinal Submucosa as a Biomaterial for Achilles-Tendon Repair in a Dog-Model. Journal of Biomedical Materials Research, 1995. 29(8): p. 977-985.
10. Milthorpe, B.K., Xenografts for Tendon and Ligament Repair. Biomaterials, 1994. 15(10): p. 745-752.
11. Maletius, W. and J. Gillquist, Long-term results of anterior cruciate ligament reconstruction with a dacron prosthesis - The frequency of osteoarthritis after seven to eleven years. American Journal of Sports Medicine, 1997. 25(3): p. 288-293.
12. Teh, T.K.H., S.L. Toh, and J.C.H. Goh, Aligned Hybrid Silk Scaffold for Enhanced Differentiation of Mesenchymal Stem Cells into Ligament Fibroblasts. Tissue Engineering Part C-Methods, 2011. 17(6): p. 687-703.
13. Miller, S.L. and J.N. Gladstone, Graft selection in anterior cruciate ligament reconstruction. Orthopedic Clinics of North America, 2002. 33(4): p. 675-+.
14. Liu, H.F., et al., A comparison of rabbit mesenchymal stem cells and anterior cruciate ligament fibroblasts responses on combined silk scaffolds. Biomaterials, 2008. 29(10): p. 1443-1453.
15. Shen, W.L., et al., The effect of incorporation of exogenous stromal cell-derived factor-1 alpha within a knitted silk-collagen sponge scaffold on tendon regeneration. Biomaterials, 2010. 31 (28): p. 7239-7249.
16. Sahoo, S., S.L. Toh, and J.C.H. Goh, A bFGF-releasing silk/PLGA-based biohybrid scaffold for ligament/tendon tissue engineering using mesenchymal progenitor cells. Biomaterials, 2010. 31 (11): p. 2990-2998.
17. Fan, H.B., et al., Anterior cruciate ligament regeneration using mesenchymal stem cells and silk scaffold in large animal model. Biomaterials, 2009. 30(28): p. 4967-4977.
18. Ge, Z.G., et al., Biomaterials and scaffolds for ligament tissue engineering. Journal of Biomedical Materials Research Part A, 2006. 77A(3): p. 639-652.
19. D.I.Zeugolis, J.C.Y.C., and A. Pandit, Tendons: Engineering of Functional Tissues. Tissue Engineering, 2011 : p. 36.
20. Teh, T.K.H., S.L. Toh, and J.C.H. Goh, Optimization of the silk scaffold sericin removal process for retention of silk fibroin protein structure and mechanical properties. Biomedical Materials, 2010. 5(3).
21. Wang, X., et al., Improved human tenocyte proliferation and differentiation in vitro by optimized silk degumming. Biomedical Materials, 2011. 6(3).
22. Moy, R.L., A. Lee, and A. Zalka, Commonly Used Suture Materials in Skin Surgery. American Family Physician, 1991. 44(6): p. 2123-2128.
23. Altman, G.H., et al., Silk-based biomaterials. Biomaterials, 2003. 24(3): p. 401-416.
24. Wang, Y.Z., et al., Stem cell-based tissue engineering with silk biomaterials. Biomaterials, 2006. 27(36): p. 6064-6082.
25. Minoura, N., et al., Attachment and Growth of Cultured Fibroblast Cells on Silk Protein Matrices. Journal of Biomedical Materials Research, 1995.29(10): p. 1215-1221.
26. Inouye, K., et al., Use of Bombyx mori silk fibroin as a substratum for cultivation of animal cells. Journal of Biochemical and Biophysical Methods, 1998. 37(3): p. 159-164.
27. Zhang, Q.A., S.Q. Yan, and M.Z. Li, Porous Materials Based on Bombyx mori Silk Fibroin. Textile Bioengineering and Informatics Symposium Proceedings, Vols 1-3, 2010: p. 254-261.
28. Sandmann, G.H. and T. Tischer, Tissue Engineering of the ACL - Efforts and Achievements. Anterior Cruciate Ligament (Acl): Causes of Injury, Adverse Effects and Treatment Options, 2010: p. 225-246.
29. Panas, E., C.J. Gatt, and M.G. Dunn, In Vitro Analysis of a Tissue-Engineered Anterior Cruciate Ligament Scaffold. 2009 35th Annual Northeast Bioengineering Conference, 2009: p. 286-287.
30. Laurencin, C.T. and J.W. Freeman, Ligament tissue engineering: An evolutionary materials science approach. Biomaterials, 2005. 26(36): p. 7530-7536.
31. Weitzel, P.P., et al., Future direction of the treatment of ACL ruptures. Orthopedic Clinics of North America, 2002. 33(4): p. 653-+.
32. Horan, R.L., et al., Yarn design for functional tissue engineering. Journal of Biomechanics, 2006. 39(12): p. 2232-2240.
33. Altman, G.H., et al., Silk matrix for tissue engineered anterior cruciate ligaments. Biomaterials, 2002. 23(20): p. 4131-4141.
34. Min, B.M., et al., Formation of silk fibroin matrices with different texture and its cellular response to normal human keratinocytes. International Journal of Biological Macromolecules, 2004. 34(5): p. 281-288.
35. Min, B.M., et al., Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials, 2004. 25(7-8): p. 1289-1297.
36. Fang, Q., et al., In vitro and in vivo research on using Antheraea pernyi silk fibroin as tissue engineering tendon scaffolds. Materials Science & Engineering C-Biomimetic and Supramolecular Systems, 2009. 29(5): p. 1527-1534.
37. Chen, X., et al., Synergic Combination of Collagen Matrix with Knitted Silk Scaffold Regenerated Ligament with More Native Microstructure in Rabbit Model. 13th International Conference on Biomedical Engineering, Vols 1-3, 2009. 23(1-3): p. 1195-1198.
38. Altman, G.H., et al., “The use of long-term bioresorbable scaffolds for anterior cruciate ligament repair” (vol 16, pg 177, 2008). Journal of the American Academy of Orthopaedic Surgeons, 2008. 16(8): p. 22a-22a.
39. Horan, R.L., SeriACLTM Device (Gen IB) Trial for Anterior Cruciate Ligament (ACL) Repair, Serica Technologies, Inc. 2009(NCT00775892).
40. Bernardino, S., ACL prosthesis: any promise for the future? (Retracted Article. See vol 18, pg 1814, 2010). Knee Surgery Sports Traumatology Arthroscopy, 2010. 18(6): p. 797-804.
41. Mascarenhas, R. and P.B. MacDonald, Anterior cruciate ligament reconstruction: a look at prosthetics-past, present and possible future. Mcgill J Med, 2008. 11(1): p. 29-37.
42. Wen, C.Y., et al., The Use of Brushite Calcium Phosphate Cement for Enhancement of Bone-Tendon Integration in an Anterior Cruciate Ligament Reconstruction Rabbit Model. Journal of Biomedical Materials Research Part B- Applied Biomaterials, 2009. 89B(2): p. 466-474.
43. Huangfu, X.Q. and J.Z. Zhao, Tendon-bone healing enhancement using injectable tricalcium phosphate in a dog anterior cruciate ligament reconstruction model. Arthroscopy-the Journal of Arthroscopic and Related Surgery, 2007. 23(5): p. 455-462.
44. Soon, M.Y.H., et al., An analysis of soft tissue allograft anterior cruciate ligament reconstruction in a rabbit model - A short-term study of the use of mesenchymal stem cells to enhance tendon osteointegration. American Journal of Sports Medicine, 2007. 35(6): p. 962-971.
45. Lim, J.K., et al., Enhancement of tendon graft osteointegration using mesenchymal stem cells in a rabbit model of anterior cruciate ligament reconstruction. Arthroscopy-the Journal of Arthroscopic and Related Surgery, 2004. 20(9): p. 899-910.
46. Rodeo, S.A., et al., Use of recombinant human bone morphogenetic protein-2 to enhance tendon healing in a bone tunnel. American Journal of Sports Medicine, 1999. 27(4): p. 476-488.
47. Yu, Y., et al., Bone morphogenetic proteins and Smad expression in ovine tendon-bone healing. Arthroscopy-the Journal of Arthroscopic and Related Surgery, 2007. 23(2): p. 205-210.
48. Beynnon, B.D. and A.A. Amis, In vitro testing protocols for the cruciate ligaments and ligament reconstructions. Knee Surg Sports Traumatol Arthrosc, 1998: p. 7.
49. Nurmi, J., P. Kannus, and S. H, Interference Screw Fixation of Soft Tissue Grafts in Anterior Cruciate Ligament Reconstruction: Part 2. Am J Sports Med, 2004. 32(2): p. 5.
50. Coleridge, S.D. and A.A. Amis, A comparison of five tibial-fixation systems in hamstring-graft anterior cruciate ligament reconstruction. Knee Surgery Sports Traumatology Arthroscopy, 2004. 12(5): p. 391-397.
51. Woo, S.L.Y., et al., Tensile Properties of the Human Femur-Anterior Cruciate Ligament-Tibia Complex - the Effects of Specimen Age and Orientation. American Journal of Sports Medicine, 1991. 19(3): p. 217-225.
52. Noyes, F.R. and E.S. Grood, Strength of Anterior Cruciate Ligament in Humans and Rhesus-Monkeys. Journal of Bone and Joint Surgery-American Volume, 1976. 58(8): p. 1074-1082.
Claims (28)
- 可撓性要素(10)を、特に天然または合成の靭帯または腱の形態で、骨(20)に固定するための装置であって、
−前記可撓性要素(10)を保持するように作られたインサート(100)、および、
−アンカー(200)であって、前記インサート(100)が前記アンカー(200)の中に挿入されるように作られ、前記アンカー(200)は、前記可撓性要素(10)を前記骨(20)に固定するために、前記アンカー(200)の中に挿入された前記インサート(100)と共に前記骨(20)のボアホール(2)の中に挿入されるように作られた、アンカー(200)、
を含む、装置。 - 前記インサート(100)は、骨誘導性および/または骨伝導性の材料から形成されるか、または骨誘導性および/または骨伝導性の材料を含むという点で特徴づけられる、請求項1に記載の装置。
- 前記アンカー(200)は、前記アンカー(200)の中に挿入された前記インサート(100)と共に挿入方向(Z)に沿って前記ボアホール(2)の中に挿入されるように作られたという点で特徴づけられる、請求項1または2に記載の装置。
- 前記アンカー(200)は、ヘッド部分(201)ならびに前記ヘッド部分(201)から突出する第1のおよび第2の脚(210、220)を含み、特に前記脚(210、220)は、前記ヘッド部分(201)と一体に形成され、特に前記脚(210、220)は、挿入方向(Z)において前記ヘッド部分(201)から突出するという点で特徴づけられる、請求項1〜3のいずれか一項に記載の装置
- 前記ヘッド部分(201)は、環状の形状からなり、特に前記ヘッド部分(201)は、前記可撓性要素(10)を通過させるための開口部(202)を含むという点で特徴づけられる、請求項4に記載の装置。
- 前記ヘッド部分(201)は、前記可撓性要素(10)を迂回させるための2つの向かい合った切り欠き(203、204)を含み、各々の切り欠き(203、204)は、前記ヘッド部分(201)の境界領域において形成されるという点で特徴づけられる、請求項4に記載の装置。
- 前記インサート(100)が前記アンカー(200)の中に挿入されるとき、前記インサート(100)は、前記アンカー(200)の前記脚(210、220)の間に配置されるという点で特徴づけられる、請求項4〜6のいずれか一項に記載の装置。
- 前記インサート(100)は、前記インサート(100)が前記アンカー(200)の中に挿入されるときにフィットする様式で前記脚(210、220)を受け入れるように作られている第1のおよび第2の案内凹部(110、120)を含むという点で特徴づけられる、請求項4〜7のいずれか一項に記載の装置。
- 各々の案内凹部(110、120)は、前記インサート(100)の表面(110a、120a)によって境界を定められ、前記2つの表面(110a、120a)は、互いに背を向け、2つの向かい合った境界領域(112、113、122、123)は、それぞれの表面(110a、120a)から突出し、特に前記2つの表面(110a、120a)は、凸であるという点で特徴づけられる、請求項8に記載の装置。
- 各々の境界領域(112、113、122、123)は、前記アンカー(200)が意図されるように前記インサート(100)と共に前記骨(20)の前記ボアホール(2)の中に挿入されるときに、前記骨(20)に接触するように作られている接触面(112a、113a、122a、123a)を含み、その接触面(112a、113a、122a、123a)は、それぞれの前記案内凹部(110、120)に沿って延びるという点で特徴づけられる、請求項9に記載の装置。
- 前記アンカー(200)は、前記骨(20)との接触のための外部(200a)を含み、特に前記外部(200a)は、歯のある表面を含み、特にそれぞれの前記接触面(112a、113a、122a、123a)は、前記インサート(100)が意図されるように前記アンカー(200)の中に挿入されるときに、前記アンカー(200)の前記外部(200a)と同一平面上にあるという点で特徴づけられる、請求項1〜10のいずれか一項に記載の装置。
- 前記インサート(100)の領域(110a、120a)は、前記アンカー(200)の中への前記インサート(100)の挿入に際して、前記インサート(100)が特に前記インサート(100)の前記表面(110a、120a)によって前記脚(210、220)を互いから遠ざけて押すようにテーパーづけられ、特に前記アンカー(200)は、前記インサート(100)が前記アンカー(200)の中に完全には挿入されない第1の位置において前記アンカー(200)の中に挿入されている前記インサート(100)と共に前記挿入方向(Z)において前記ボアホール(2)の中に挿入されるように作られ、特に前記インサート(100)は、前記アンカー(200)が意図されるように前記骨(20)の前記ボアホール(2)の中に挿入されるときに、前記挿入方向(Z)と反対に第2の位置に引張られるように作られ、その第2の位置において前記インサート(100)は、前記アンカー(200)の中に完全に挿入されて、前記骨(20)に対して前記脚(210、220)を押しつけるという点で特徴づけられる、請求項4に記載の、または請求項4を参照するときに請求項5〜11のいずれか一項に記載の装置。
- 各々の前記脚(210、220)は、内面(210a、220a)を含み、前記2つの内面(210a、220a)は、互いに対面し、特に前記内面(210a、220a)は、凹であるという点で特徴づけられる、請求項4に記載の、または請求項4を参照するときに請求項5〜12のいずれか一項に記載の装置。
- 各々の前記内面(210a、220a)は、案内凹部(110、120)の関連した表面(110a、120a)上に留まるように作られるという点で特徴づけられる、請求項9および13に記載の装置。
- 前記インサート(100)は、第1の壁領域(101)および第2の壁領域(102)を含み、特に前記第1の案内凹部(110)は、前記第1の壁領域(101)において形成され、特に前記第2の案内凹部(120)は、前記第2の壁領域(102)において形成されるという点で特徴づけられる、請求項1〜14のいずれか一項に記載の装置。
- 前記2つの壁領域(101、102)は、接続領域(103)によって一体に接続され、特に前記接続領域(103)は、前記可撓性要素(10)の接触のための表面(103a)を含み、特に前記表面(103a)は、凹であるという点で特徴づけられる、請求項15に記載の装置。
- 前記インサート(100)は、前記可撓性要素(10)を受け入れるための溝(104)を含み、特に前記溝(104)は、前記2つの壁領域(101、102)および前記接続領域(103)によって境界を定められるという点で特徴づけられる、請求項1〜16のいずれか一項に記載の装置。
- 前記装置(1)は、前記可撓性要素(10)を含むという点で特徴づけられる、請求項1〜17のいずれか一項に記載の装置。
- 前記可撓性要素(10)は、特に前記インサート(100)に接触するように前記インサート(100)の周りに(特に前記接続領域(103)の周りに)置かれ、特に前記可撓性要素(10)は、前記溝(104)の中に配置されるという点で特徴づけられる、請求項18に記載の装置。
- 前記可撓性要素(10)は、前記ヘッド部分(201)の前記開口部(202)を通過するという点で特徴づけられる、請求項5および請求項18または19に記載の装置。
- 前記可撓性要素(10)は、前記ヘッド部分(201)の前記切り欠き(203、204)によって通るという点で特徴づけられる、請求項6および請求項18または19に記載の装置。
- 前記可撓性要素(10)は、天然の靭帯または腱であるという点で特徴づけられる、請求項18〜21のいずれか一項に記載の装置。
- 可撓性要素(10)は、合成の靭帯または腱(特にACLスキャフォールド)であるという点で特徴づけられる、請求項18〜21のいずれか一項に記載の装置。
- 前記可撓性要素(10)は、2本の撚りコード(300)を含み、各々のコード(300)は、144本の撚り糸(301)を含み、各々の糸(301)は、2本の撚り束(302)を含み、各々の束は、6本の繊維(303)を含み、その繊維(303)は、特にフィブロインを含むという点で特徴づけられる、請求項23または請求項18〜21のいずれか一項に記載の装置。
- 前記可撓性要素(10)は、3本のブレード加工したコード(300)を含み、各々のコード(300)は、96本の撚り糸(301)を含み、各々の糸(301)は、2本の撚り束(302)を含み、各々の束(302)は、6本の繊維(303)を含み、その繊維(303)は、特にフィブロインを含むという点で特徴づけられる、請求項23または請求項18〜21のいずれか一項に記載の装置。
- 前記インサート(100)は、以下の物質、リン酸三カルシウム、ヒドロキシルアパタイト、リン酸カルシウム、ケイ酸カルシウム、またはシリケート置換リン酸カルシウムのうちの1つを含むという点で特徴づけられる、請求項1〜25のいずれか一項に記載の装置。
- 前記アンカー(200)は、以下の物質、ポリエーテルエーテルケトン、ポリ乳酸、ポリ(乳−co−グリコール酸)、ポリ−ε−カプロラクトン、チタンベース合金、またはマグネシウムベース合金のうちの1つを含むという点で特徴づけられる、請求項1〜26のいずれか一項に記載の装置。
- 骨(20)におけるボアホール(2)の中に請求項1〜27のいずれか一項に記載の装置(1)を挿入するためのツールセットであって、前記ボアホール(2)の中に前記装置(1)を押し込むための少なくとも第1のツール(40)を含み、前記第1のツール(40)は、前記ボアホール(2)の中に前記装置(1)を押し込むために前記アンカー(200)と(特に前記アンカー(200)の前記ヘッド部分(201)と)係合するように作られた自由端部(42)を有する延びた軸(41)を含み、前記延びた軸(41)は、前記骨(20)の前記ボアホール(2)の中への前記装置(1)の挿入に際して前記可撓性要素(10)を受け入れるための溝(43)を含む、ツールセット。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12192333.8 | 2012-11-13 | ||
EP12192333 | 2012-11-13 | ||
PCT/EP2013/073759 WO2014076147A2 (en) | 2012-11-13 | 2013-11-13 | Device for fixation of a flexible element, particularly a natural or synthetical ligament or tendon, to a bone |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015533598A true JP2015533598A (ja) | 2015-11-26 |
JP6587542B2 JP6587542B2 (ja) | 2019-10-09 |
Family
ID=47177812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015541190A Expired - Fee Related JP6587542B2 (ja) | 2012-11-13 | 2013-11-13 | 可撓性要素、特に天然または合成の靭帯または腱を骨に固定するための装置 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20160270902A1 (ja) |
EP (1) | EP2919661A2 (ja) |
JP (1) | JP6587542B2 (ja) |
CN (1) | CN104780850B (ja) |
WO (1) | WO2014076147A2 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101612383B1 (ko) | 2016-01-19 | 2016-04-14 | 주식회사 에이알씨코리아 | 내외측 봉합사를 구비한 오메가 노트형 슬리브 앵커 |
KR101634796B1 (ko) * | 2016-01-19 | 2016-06-29 | 주식회사 에이알씨코리아 | 오메가 노트형 슬리브 앵커 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3042632A1 (en) * | 2015-01-12 | 2016-07-13 | Universität Zürich | Device for tendon and ligament reconstruction |
US10682131B2 (en) | 2016-07-05 | 2020-06-16 | Crossroads Extremity Systems, Llc | Intra joint stabilization construct |
CN109152567B (zh) * | 2016-05-18 | 2021-06-18 | 奥林巴斯株式会社 | 超声波内窥镜 |
US10383578B2 (en) | 2016-06-03 | 2019-08-20 | RoboDiagnostics LLC | Analysis system and method for determining joint equilibrium position |
US10842439B2 (en) | 2016-06-03 | 2020-11-24 | RoboDiagnostics LLC | Biomechanical characterization and analysis of joints |
US10506951B2 (en) | 2016-06-03 | 2019-12-17 | RoboDiagnostics LLC | Joint play quantification and analysis |
US10849550B2 (en) | 2016-06-03 | 2020-12-01 | RoboDiagnostics LLC | Robotic joint testing apparatus and coordinate systems for joint evaluation and testing |
US10595751B2 (en) | 2016-09-15 | 2020-03-24 | RoboDiagnostics LLC | Multiple test knee joint analysis |
US10596057B2 (en) | 2016-09-15 | 2020-03-24 | RoboDiagnostics LLC | Off-axis motion-based analysis of joints |
CN106510908B (zh) * | 2016-12-01 | 2018-03-27 | 周大勇 | 一种用于膝关节交叉韧带重建的内植装置 |
US10743981B2 (en) * | 2017-02-16 | 2020-08-18 | L. Pearce McCarty, III | Tendon anchoring |
EP3449872A1 (en) * | 2017-08-30 | 2019-03-06 | Universität Zürich | Implant system for tendon-bone interface repair |
AU2017441106A1 (en) * | 2017-12-01 | 2020-06-11 | Crossroads Extremity Systems, Llc | Intra joint stabilization construct |
EP3856045A4 (en) * | 2018-09-25 | 2022-10-05 | The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | SURGICAL LINE ATTACHMENT DEVICE AND METHODS OF USE |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5993459A (en) * | 1996-10-04 | 1999-11-30 | Larsen; Scott | Suture anchor installation system with insertion tool |
US20070218424A1 (en) * | 2006-03-20 | 2007-09-20 | Inion Oy | Implant and use thereof |
JP2008535544A (ja) * | 2005-03-10 | 2008-09-04 | タイコ ヘルスケア グループ リミテッド パートナーシップ | 縫合糸固定具 |
US7713285B1 (en) * | 2003-07-02 | 2010-05-11 | Biomet Sports Medicine, Llc | Method and apparatus for suture anchors with a vertical eyelet |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5480403A (en) * | 1991-03-22 | 1996-01-02 | United States Surgical Corporation | Suture anchoring device and method |
US5632748A (en) * | 1993-06-14 | 1997-05-27 | Linvatec Corporation | Endosteal anchoring device for urging a ligament against a bone surface |
US5584835A (en) * | 1993-10-18 | 1996-12-17 | Greenfield; Jon B. | Soft tissue to bone fixation device and method |
US5464427A (en) * | 1994-10-04 | 1995-11-07 | Synthes (U.S.A.) | Expanding suture anchor |
US5702397A (en) * | 1996-02-20 | 1997-12-30 | Medicinelodge, Inc. | Ligament bone anchor and method for its use |
US5935129A (en) * | 1997-03-07 | 1999-08-10 | Innovasive Devices, Inc. | Methods and apparatus for anchoring objects to bone |
US6887271B2 (en) * | 2001-09-28 | 2005-05-03 | Ethicon, Inc. | Expanding ligament graft fixation system and method |
US6902932B2 (en) * | 2001-11-16 | 2005-06-07 | Tissue Regeneration, Inc. | Helically organized silk fibroin fiber bundles for matrices in tissue engineering |
US6942666B2 (en) * | 2002-03-29 | 2005-09-13 | Ethicon, Inc. | Expandable cable anchor |
US7620246B2 (en) * | 2002-07-30 | 2009-11-17 | Fujifilm Corporation | Method and apparatus for image processing |
US20040068262A1 (en) * | 2002-10-02 | 2004-04-08 | Mark Lemos | Soft tissue fixation implant |
US20060074422A1 (en) * | 2004-09-27 | 2006-04-06 | Story Brooks J | Suture anchor and void filler combination |
US7976565B1 (en) * | 2004-12-07 | 2011-07-12 | Biomet Sports Medicine, Llc | Expanding suture anchor having an actuator pin |
US7572283B1 (en) * | 2004-12-07 | 2009-08-11 | Biomet Sports Medicine, Llc | Soft tissue rivet and method of use |
US8986345B2 (en) * | 2004-12-07 | 2015-03-24 | Biomet Sports Medicine, Llc | Expanding suture anchor having an actuator pin |
US20060149258A1 (en) * | 2004-12-14 | 2006-07-06 | Sousa Joaquim P G | Surgical tool and method for fixation of ligaments |
US20060178702A1 (en) * | 2005-02-10 | 2006-08-10 | Inion Ltd. | Apparatus for attaching sutures |
DE102005009492A1 (de) * | 2005-02-24 | 2006-08-31 | Lob, Günter, Prof. Dr. med. | Befestigungselement |
US7785357B2 (en) * | 2005-12-14 | 2010-08-31 | Arthrex, Inc. | Expanding plug for tendon fixation |
AU2007227318B2 (en) * | 2006-03-20 | 2013-02-14 | Cayenne Medical, Inc | Devices, systems, and methods for material fixation |
US7828820B2 (en) * | 2006-03-21 | 2010-11-09 | Biomet Sports Medicine, Llc | Method and apparatuses for securing suture |
WO2007109769A1 (en) * | 2006-03-22 | 2007-09-27 | C2M Medical, Inc. | Suture passer devices and uses thereof |
US20090043342A1 (en) * | 2006-03-28 | 2009-02-12 | Yosef Freedland | Flat Shaft Fasteners |
EP2043555A1 (fr) * | 2006-06-23 | 2009-04-08 | Michel Collette | Dispositif d'ancrage osseux |
US7713648B2 (en) * | 2007-07-23 | 2010-05-11 | Utc Power Corporation | Fuel cell cover plate tie-down |
JP5341901B2 (ja) * | 2007-10-25 | 2013-11-13 | スミス アンド ネフュー インコーポレーテッド | アンカーアセンブリ |
US9216077B2 (en) * | 2008-05-16 | 2015-12-22 | Mimedx Group, Inc. | Medical constructs of twisted lengths of collagen fibers and methods of making same |
US8709040B2 (en) * | 2008-06-26 | 2014-04-29 | Vitasynergies, Llc | Suture anchor, guide for locating a hole in a bone, and suture anchor delivery tool |
US7750717B2 (en) * | 2008-07-25 | 2010-07-06 | Texas Instruments Incorporated | Single supply level shifter circuit for multi-voltage designs, capable of up/down shifting |
US20100049249A1 (en) * | 2008-08-25 | 2010-02-25 | Linvatec Corporation | Suture anchor extension |
US8523902B2 (en) * | 2009-01-30 | 2013-09-03 | Kfx Medical Corporation | System and method for attaching soft tissue to bone |
EP2421471A1 (en) * | 2009-04-20 | 2012-02-29 | Peter Michael Sutherland Walker | Swivel screw ligament fixation device |
WO2011160166A1 (en) * | 2010-06-22 | 2011-12-29 | Peter Michael Sutherland Walker | Ligament retainer device and method |
GB201106434D0 (en) * | 2011-04-15 | 2011-06-01 | Xiros Ltd | Implantable surgical cord anchor manufactured by rapid processing |
US10299907B2 (en) * | 2011-04-16 | 2019-05-28 | Kyon Ag | Prosthetic system for orthopedic repair |
US9855028B2 (en) * | 2012-04-06 | 2018-01-02 | Arthrocare Corporation | Multi-suture knotless anchor for attaching tissue to bone and related method |
KR102257312B1 (ko) * | 2013-03-14 | 2021-05-28 | 케이에프엑스 메디컬, 엘엘씨 | 조직 포획 본 앵커 |
US20140288595A1 (en) * | 2013-03-20 | 2014-09-25 | Rajiv D. Pandya | Soft tissue interference fit anchor system |
-
2013
- 2013-11-12 US US14/442,404 patent/US20160270902A1/en not_active Abandoned
- 2013-11-13 EP EP13802896.4A patent/EP2919661A2/en not_active Withdrawn
- 2013-11-13 JP JP2015541190A patent/JP6587542B2/ja not_active Expired - Fee Related
- 2013-11-13 WO PCT/EP2013/073759 patent/WO2014076147A2/en active Application Filing
- 2013-11-13 CN CN201380059221.XA patent/CN104780850B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5993459A (en) * | 1996-10-04 | 1999-11-30 | Larsen; Scott | Suture anchor installation system with insertion tool |
US7713285B1 (en) * | 2003-07-02 | 2010-05-11 | Biomet Sports Medicine, Llc | Method and apparatus for suture anchors with a vertical eyelet |
JP2008535544A (ja) * | 2005-03-10 | 2008-09-04 | タイコ ヘルスケア グループ リミテッド パートナーシップ | 縫合糸固定具 |
US20070218424A1 (en) * | 2006-03-20 | 2007-09-20 | Inion Oy | Implant and use thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101612383B1 (ko) | 2016-01-19 | 2016-04-14 | 주식회사 에이알씨코리아 | 내외측 봉합사를 구비한 오메가 노트형 슬리브 앵커 |
KR101634796B1 (ko) * | 2016-01-19 | 2016-06-29 | 주식회사 에이알씨코리아 | 오메가 노트형 슬리브 앵커 |
Also Published As
Publication number | Publication date |
---|---|
WO2014076147A2 (en) | 2014-05-22 |
JP6587542B2 (ja) | 2019-10-09 |
US20160270902A1 (en) | 2016-09-22 |
WO2014076147A3 (en) | 2014-07-31 |
CN104780850B (zh) | 2017-08-29 |
CN104780850A (zh) | 2015-07-15 |
EP2919661A2 (en) | 2015-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6587542B2 (ja) | 可撓性要素、特に天然または合成の靭帯または腱を骨に固定するための装置 | |
US11076846B2 (en) | Methods and procedures for ligament repair | |
AU2017291837B2 (en) | Indirect method of articular tissue repair | |
US10959829B2 (en) | Device for tendon and ligament reconstruction | |
Li et al. | A novel silk-based artificial ligament and tricalcium phosphate/polyether ether ketone anchor for anterior cruciate ligament reconstruction–Safety and efficacy in a porcine model | |
JP7330700B2 (ja) | 回旋筋腱板修復のための設計された腱移植片 | |
Li | A hybrid graft of silk-based artificial ligament and TCP/PEEK anchorage for ACL reconstruction | |
US20230000614A1 (en) | Acl repair method using femoral attachment | |
Fink | Histologic and histomorphometric evaluation of silk-based anterior cruciate ligament scaffolds in sheep after two years of implantation | |
Cole et al. | Anterior Cruciate Ligament Reconstruction in a Translational Model in Sheep Using Bio-Integrative Mineral Fiber-Reinforced Screws | |
WO2023278654A1 (en) | Arthroscopic acl repair system and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20161111 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170929 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20171017 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20180112 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20180315 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180417 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180918 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20181217 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190213 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190315 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190813 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190910 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6587542 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |